The growth of the global albumin & creatinine tests market is driven by factors such as the growing prevalence of kidney disorders, the rising adoption of POC diagnostics, and the increasing prevalence of chronic conditions.
The
report Albumin & Creatinine Tests Market is projected to reach USD
2,103 million by 2025 from USD 987 million in 2020, at a CAGR of 16.3%.
Download
PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=156696568
The dipsticks & kits products segment accounted for the
largest share of the albumin & creatinine tests market, by product segment,
in 2019
Based
on product, the albumin & creatinine tests market is segmented into
dipsticks & kits, analyzers, cartridges, and reagents & other
consumables. In 2019, the dipsticks & kits segment accounted for the
largest share in this market. The frequent purchase of these products compared
to instruments like analyzers and cartridges and the increasing use of
kit-based rapid techniques for albumin & creatinine tests drive market
growth.
Urine Tests segment to register the highest growth rate during
the forecast period
Based
on type, the albumin & creatinine tests market is segmented into urine
tests and blood & serum creatinine tests. In 2019, urine tests accounted
for the largest share in this market. Factors such as the rapid growth in the
diagnostics segment and the increasing demand for rapid and easy-to-use urine
tests drive the growth of this segment.
North America is the largest regional market for albumin &
creatinine tests market
The
global albumin & creatinine tests market is segmented into North America,
Europe, the Asia Pacific, Latin America, and the Middle East and Africa. In
2019, North America accounted for the largest share in the global albumin &
creatinine tests market. The large share of this regional segment can primarily
be attributed to the growth in demand for rapid urine tests, increasing
prevalence of chronic conditions leading to various kidney diseases, rising
government initiatives, and growing geriatric population.
Request
for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=156696568
Top
Key Players:-
The
major players operating in this market are Thermo Fisher Scientific, Inc. (US),
Roche Diagnostics (Switzerland), PromoCell GmbH (Germany), Abbott Laboratories
(US), Siemens Healthineers (Germany), Danaher Corporation (US), Sysmex
Corporation (Japan), Ortho Clinical Diagnostics (US), Randox Laboratories (UK),
FUJIFILM Wako Pure Chemical Corporation (Japan), Abbexa Ltd. (UK), ACON
Laboratories, Inc. (US), Arbor Assays Inc. (US), ARKRAY Global Business Inc.
(Japan), Aviva Systems Biology (US), Axxora, LLC (UK), BioAssay Systems (US),
Nova Biomedical (US), Quantimetrix Corporation (US), RayBiotech Inc. (US),
Sekisui Diagnostics PEI Inc. (US), Teco Diagnostics (US), Tulip Diagnostics
(India), ulti med Products GmbH (Germany), and URIT Medical Electronic Co.,
Ltd. (China).
No comments:
Post a Comment